Supply of Levothyroxine Sodium 112 MCG Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the annual supply of 12,379 bottles, each containing 90 tablets of Levothyroxine Sodium 112 MCG, totaling approximately 1.11 million tablets per year for a five-year period, to support high-volume thyroid hormone replacement therapy needs. This is a subcontract under the Department of Defense’s Medical Supply Chain FSBG, governed by NAICS code 325412 for pharmaceutical preparation manufacturing, with a solicitation window opening on July 13, 2026, and a firm response deadline of August 13, 2026. The product is intended to meet sustained demand within federal healthcare infrastructure, requiring consistent, quality-assured delivery of a critical medication across the contract term. While the place of performance and point of contact details are unspecified, the procurement is publicly accessible via the DIBBS platform for qualified suppliers to respond.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN FSGB
Same awarding agency
